Medical equipment company Medigus Ltd. (TASE:MDGS) said yesterday that the US Food and Drug Administration (FDA) has turned down its application to begin a multi-center trial of its SRS endoscopy system for the treatment of Gastro Esophageal Reflux Disease (GERD). The company had submitted a 510K application to secure FDA approval to commence marketing of its product.
